BNTX BioNTech SE

$96.73▲ +0.34% Healthcare Other
After hours $97.60▲ +0.90% Sep 11, 7:59 PM ET
Volume 1.18M Avg Volume (10D) 1.19M
Key Metrics & Fundamentals
Market Cap
$24.30B
P/E Ratio
–
Div Yield
–%
52W Range
79.52 - 124.00
% vs 50 MA
-0.13%
% vs 200 MA
-0.93%
RSI-14
43.6
MACD Histogram
-1.6300
Beta (1Y vs SPY)
0.90
Free Cash Flow
-$44.90M
Gross Rev
$105.60M
Gross Profit
$8.60M
EBITDA
-$606.40M
COGS
$97.00M
Operating Exp
$947.30M
Operating Income
-$938.70M
EBIT
-$938.70M
Pretax Income
-$858.70M
Net Income
-$820.80M
EPS (Diluted)
-3.24
Price & Volume History
Loading chart…
Recent News
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
24/7 Wall St. · Sep 11, 2026 3:56 PM
European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
MT Newswires · Sep 10, 2026 3:34 PM
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT Newswires · Sep 8, 2026 3:28 PM
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
Investing.com · Sep 8, 2026 11:28 AM
BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?
Insider Monkey · Sep 8, 2026 12:33 AM
European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading
MT Newswires · Sep 4, 2026 3:05 PM
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
24/7 Wall St. · Sep 1, 2026 6:00 PM
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?
24/7 Wall St. · Sep 1, 2026 5:12 PM
BioNTech (BNTX) Ended A Phase 2 Colorectal Cancer Trial
Simply Wall St. · Aug 29, 2026 1:07 AM
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Aug 28, 2026 8:06 PM
Financial Overview - Income Statement Quarterly

See BNTX's money flow as a full page

Social Sentiment
Avg +0.88 · 11 posts
DiscussionTradePriceTargetBioNTech ($BNTX) is arguably the most undervalued stock in the biotech sector today and i dont understand why
r/stocks · Jul 6, 2026
very_positive +0.80
DDNewsTradeBNTX ASCO 2026 DD
r/wallstreetbets · May 31, 2026
The author expresses strong bullish sentiment, predicting a significant stock price increase based on ASCO 2026 data.
very_positive +0.80
NewsDiscussionTradePriceTargetBNTX is about to go full send at ASCO and nobody’s talking about it 🚀🧬
r/wallstreetbets · May 18, 2026
The author believes BNTX presents a strong risk/reward opportunity and anticipates a significant stock pop.
very_positive +1.00
NewsTradeDD$BNTX ASCO 2026 conference
r/wallstreetbets · May 18, 2026
The post focuses on positive clinical trial data and potential stock surge based on BNTX research.
positive +0.80
NewsDiscussionTrade$BNTX YOLO – Betting $120k that cancer gets cured in the next few years
r/wallstreetbets · Apr 21, 2026
Strong bullish sentiment regarding BNTX's potential in cancer treatment and the founders' dedication.
very_positive +1.00
Page 1 of 3 (11 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙